Table 2.
Summary estimates for proportion of hematological cancer patients with SARS-CoV-2 Infection.
| Subgroup | Type of Model | Heterogeneity |
Odds Ratio |
Publication Bias |
|||||
|---|---|---|---|---|---|---|---|---|---|
| I2 (%) | PH | OR | 95% CI | Ztest | POR | PBeggs | PEggers | ||
| Overall | Random | 89.33 | ≤ 0.001 | 0.165 | 0.130-0.208 | -11.146 | ≤ 0.001 | 0.028 | 0.141 |
| Ethnicity | |||||||||
| Caucasian | Random | 81.42 | ≤ 0.001 | 0.188 | 0.154-0.227 | -11.949 | ≤ 0.001 | 0.536 | 0.559 |
| Asian | Random | 94.02 | ≤ 0.001 | 0.124 | 0.057-0.250 | -4.481 | ≤ 0.001 | 0.452 | 0.191 |
| Country of origin | |||||||||
| UK | Random | 71.26 | 0.031 | 0.225 | 0.175-0.285 | -7.690 | ≤ 0.001 | 1.000 | 0.872 |
| France | Fixed | 0.00 | 0.877 | 0.171 | 0.134-0.217 | -10.537 | ≤ 0.001 | NA | NA |
| China | Fixed | 35.95 | 0.195 | 0.082 | 0.062-0.109 | -15.278 | ≤ 0.001 | 0.734 | 0.603 |
NA: Not Applicable.